Press Releases on September 3, 2024 - EIN Presswire - Press Release Distribution Service

Published on September 3, 2024 - 20:05 GMT

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from ...

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies to treat a range of solid tumors designed to preserve organ function, today announced that it will host …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on September 3, 2024 - 20:05 GMT

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on August 30, 2024, the company issued inducement awards …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on September 3, 2024 - 20:05 GMT

Sportsman’s Warehouse Holdings, Inc. Announces Second Quarter 2024 Financial Results

WEST JORDAN, Utah, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. (“Sportsman's Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen weeks ended August 3, 2024. “We continued to …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

H&R Block to Participate in the Barclays Global Financial Services Conference

KANSAS CITY, Mo., Sept. 03, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) today announced that Tony Bowen, Chief Financial Officer, and Michaella Gallina, Vice President, Investor Relations and Chief Financial Officer at Wave, will host investor …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

BURLINGAME, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on September 3, 2024 - 20:05 GMT

ACM Research Expands Fan-Out Panel-Level Packaging Portfolio with Launch of Ultra C bev-p Bevel Etching Tool

New double-sided bevel etching system enhances process efficiency and reliability in copper-related applications, supporting high-precision features on large panels FREMONT, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (ACM) (NASDAQ: ACMR …

Distribution channels: Media, Advertising & PR, Technology ...

Published on September 3, 2024 - 20:05 GMT

Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference

GRAND CAYMAN, Cayman Island, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company today announced that Company management will be attending and presenting at …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on September 3, 2024 - 20:05 GMT

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on August 30, 2024, the company granted equity awards to two new employees …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 3, 2024 - 20:05 GMT

ParaZero Announces First Half of 2024 Financial Results

TEL AVIV, Israel, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft, …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President Michael …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 3, 2024 - 20:05 GMT

FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN FRANCISCO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024 in New York, …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on September 3, 2024 - 20:05 GMT

Zscaler Reports Fourth Quarter and Fiscal 2024 Financial Results

Fourth Quarter Highlights Revenue grows 30% year-over-year to $592.9 million Calculated billings grows 27% year-over-year to $910.8 million Deferred revenue grows 32% year-over-year to $1,895.0 million GAAP net loss of $14.9 million compared to GAAP net …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels ...

Twelve-month durability data from Metagenomi’s ongoing nonhuman primate (NHP) study in hemophilia A remains generally consistent with data previously released at 4.5 months NHPs remain healthy and exhibit normal weight gain; treatment is generally well …

Distribution channels: Technology ...

Published on September 3, 2024 - 20:05 GMT

GitLab Reports Second Quarter Fiscal Year 2025 Financial Results

Second Quarter Fiscal Year 2025 Highlights: Total revenue of $182.6 million, up 31% year-over-year Significant year-over-year GAAP and Non-GAAP operating margin expansion Operating cash flow of $11.7 million and Non-GAAP adjusted free cash flow of $10.8 …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across ...

FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc. (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa Clinic, P.C., one of the most highly regarded …

Distribution channels:

Published on September 3, 2024 - 20:05 GMT

Richtech Robotics Announces Closing of $21 Million Public Offering

LAS VEGAS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR), (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, today announced the closing of its previously announced public offering of an …

Distribution channels: Technology ...

Published on September 3, 2024 - 20:01 GMT

Monroe Capital Corporation Announces Third Quarter Distribution of $0.25 Per Share

CHICAGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that its Board of Directors has declared a distribution of $0.25 per share for the third quarter of 2024, payable on September 30, 2024 to …

Distribution channels: Banking, Finance & Investment Industry ...

Published on September 3, 2024 - 20:01 GMT

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

SAN CARLOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that it …

Distribution channels: Technology ...

Published on September 3, 2024 - 20:01 GMT

Galapagos receives transparency notification from FMR LLC

Mechelen, Belgium; 3 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian transparency legislation1, Galapagos received a transparency …

Distribution channels: Media, Advertising & PR, Technology ...